Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Sees Significant Decrease in Short Interest

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) was the recipient of a significant decrease in short interest during the month of January. As of January 30th, there was short interest totaling 9,581 shares, a decrease of 76.3% from the January 15th total of 40,386 shares. Based on an average daily volume of 26,462 shares, the short-interest ratio is presently 0.4 days. Currently, 0.3% of the company’s stock are sold short. Currently, 0.3% of the company’s stock are sold short. Based on an average daily volume of 26,462 shares, the short-interest ratio is presently 0.4 days.

Invesco Pharmaceuticals ETF Stock Performance

PJP traded up $0.46 during trading on Wednesday, reaching $109.57. 66,923 shares of the stock were exchanged, compared to its average volume of 70,644. The stock’s 50 day moving average price is $105.99 and its two-hundred day moving average price is $98.10. Invesco Pharmaceuticals ETF has a twelve month low of $72.25 and a twelve month high of $110.54. The stock has a market cap of $418.56 million, a P/E ratio of 15.59 and a beta of 0.50.

Institutional Investors Weigh In On Invesco Pharmaceuticals ETF

A number of institutional investors and hedge funds have recently modified their holdings of PJP. Flagship Harbor Advisors LLC grew its holdings in Invesco Pharmaceuticals ETF by 1.8% during the fourth quarter. Flagship Harbor Advisors LLC now owns 6,049 shares of the company’s stock worth $632,000 after purchasing an additional 105 shares during the period. IFP Advisors Inc lifted its position in shares of Invesco Pharmaceuticals ETF by 31.3% in the fourth quarter. IFP Advisors Inc now owns 440 shares of the company’s stock valued at $46,000 after buying an additional 105 shares during the last quarter. AE Wealth Management LLC boosted its stake in shares of Invesco Pharmaceuticals ETF by 21.5% during the 2nd quarter. AE Wealth Management LLC now owns 717 shares of the company’s stock worth $57,000 after acquiring an additional 127 shares during the period. J.W. Cole Advisors Inc. boosted its stake in shares of Invesco Pharmaceuticals ETF by 4.7% during the 4th quarter. J.W. Cole Advisors Inc. now owns 2,910 shares of the company’s stock worth $304,000 after acquiring an additional 131 shares during the period. Finally, Northwestern Mutual Wealth Management Co. increased its holdings in shares of Invesco Pharmaceuticals ETF by 5.7% during the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 2,791 shares of the company’s stock worth $258,000 after acquiring an additional 150 shares during the last quarter.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.